Home › Rhabdomyosarcoma › Texas › Dallas
Rhabdomyosarcoma clinical trials in Dallas, TX
3 studies for Rhabdomyosarcoma are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Children's Medical Center, Dallas
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
RecruitingPhase 3
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
RecruitingPhase 1/2
- The University of Texas Southwestern Medical Center, Dallas
Rhabdomyosarcoma trials in other cities
- Houston, TX6 studies
- Memphis, TN6 studies
- Washington, DC5 studies
- Philadelphia, PA4 studies
- Boston, MA4 studies
- Salt Lake City, UT4 studies
- Seattle, WA3 studies
- Baltimore, MD3 studies
- Birmingham, AL3 studies
- The Bronx, NY3 studies
- Aurora, CO3 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer52 studies
- Heart Failure43 studies
- Metastatic Cancer42 studies
- Cancer (all types)38 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity31 studies
- Ovarian Cancer28 studies
- Lung Cancer27 studies
- Bladder Cancer27 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.